U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1981
142
Substance Class Structurally Diverse
Created
by admin
on Tue Apr 01 20:36:31 GMT 2025
Edited
by admin
on Tue Apr 01 20:36:31 GMT 2025
Source Materials Class ORGANISM
Source Materials Type MAMMAL
Source Materials Parent
EQUUS CABALLUS WHOLE
Part plasma
Fraction Material Type protein
Fraction Name igg
Record UNII
475247QF1Z
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
EQUINE THYMOCYTE IMMUNE GLOBULIN
Common Name English
ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE)
WHO-DD  
Preferred Name English
ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN, EQUINE
Common Name English
ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN, EQUINE [JAN]
Common Name English
LYMPHOCYTE IMMUNE GLOBULIN ANTI-THYMOCYTE GLOBULIN (EQUINE)
Common Name English
ANTI-THYMOCYTE GLOBULIN EQUINE NOS
Common Name English
HORSE ATG
Common Name English
HORSE ANTI-THYMOCYTE GLOBULIN
Common Name English
Equine antithymocyte globulin
Common Name English
Antilymphocyte immunoglobulin (horse) [WHO-DD]
Common Name English
ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN,EQUINE [JAN]
Common Name English
EQUINE ANTI-THYMOCYTE GLOBULIN
Common Name English
Antithymocyte immunoglobulin (horse) [WHO-DD]
Common Name English
HATG
Code English
Horse antithymocyte globulin
Common Name English
Classification Tree Code System Code
WHO-ATC L04AA03
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
NCI_THESAURUS C2701
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
NCI_THESAURUS C278
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
WHO-VATC QL04AA03
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
NDF-RT N0000184163
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
Code System Code Type Description
RXCUI
973
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
NDF-RT
N0000007920
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY Immunoglobulins [Chemical/Ingredient]
FDA UNII
475247QF1Z
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108981
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
EVMPD
SUB12913MIG
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
ALTERNATIVE
RXCUI
91601
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
NDF-RT
N0000020023
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY Antibody-Surface Protein Interactions [MoA]
EVMPD
SUB12912MIG
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
DAILYMED
475247QF1Z
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
NDF-RT
N0000009689
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY Increased T Lymphocyte Destruction [PE]
RXCUI
1011
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
ALTERNATIVE RxNorm
NDF-RT
N0000178327
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY Lymphocyte Function Alteration [PE]
SMS_ID
100000090143
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
DRUG BANK
DB09312
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
NCI_THESAURUS
C80824
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
Related Record Type Details
LYMPHOCYTE IMMUNE GLOBULIN, ANTI-THYMOCYTE GLOBULIN (EQUINE)
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
EQUINE THYMOCYTE IMMUNE GLOBULIN
ACTIVE MOIETY

Agent Modifications

Modification Process Modification Role Modification Type Amount Fragment Name Fragment ID
TARGETED ANTIGEN IMMUNOLOGICAL HUMAN THYMOCYTE, AUTOLOGOUS J56RKY13OV
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966